News: BDA BOD Australia secures binding letter of intent with a Swiss manufacturer, page-142

Weird day. Some T+2 traders decided to exit and hit bid all day...even a needy one marked the close with 10,000 measley shares sold at 29..at ,3.58pm..when last half hour it trades at 30....some geese around trying to trick people into selling. Theyll be back buying tomorrow...

Demand too strong. Shares too scarce. Value too low vs competition and performance too good. Margins higher than all ....as not relying on actual MM growing.

($13m mkt cap, $4m cash, $10m EV vs $150m comps doing much less with fewer top pharma relationships)....

I know who wins....It aint MXC or MDC...or anyone relying on selling grass....t's the BDA, ESE, CPH BOT.... biopharma types with innovative pharma and MM products....not weed growers.

The valuations will switch around I believe. BDA will benefit most.

All IMHO. DYOR.

GG